Jim McDermott from AstraZeneca: AstraZeneca Presents Full Slate of Studies at ADA

With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition.

With more than 60 presentations at the American Diabetes Association's meeting AstraZeneca showed a wide range of studies all geared towards helping patients with this condition.

Jim McDermott, US Medical Lead for diabetes at AstraZeneca discussed some of the highlights from these presentations during the New Orleans meeting. McDermott cited several of the medications the company has in the field as well as work being done to improve care in the future as well.